Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-R Zahar

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Antimicrobial Resistance and Infection Control|June 10, 2025
Impact of educational interventions provided to patients with a central venous catheter and their informal caregivers: a systematic reviewL Foucault-Fruchard, N van der Mee, C Reinprecht, et al.
The Journal of Hospital Infection|July 13, 2013
Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization?T Goulenok, A Ferroni, E Bille, et al.
International Journal of Antimicrobial Agents|May 7, 2020
SARS-CoV-2 was already spreading in France in late December 2019A Deslandes, V Berti, Y Tandjaoui-Lambotte, et al.
The Journal of Hospital Infection|February 21, 2012
Is hand-rub consumption correlated with hand hygiene and rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE)-acquired infections?J R Zahar, V Masse, L Watier, et al.
Infectious Diseases Now|August 1, 2022
Prevalence and risk factors for carriage of extended-spectrum β-lactamase-producing enterobacteriaceae in rehabilitation wards in FranceI Grall-Zahar, S Rucly, Typhaine Billard-Pomares, et al.
Intensive Care Medicine|May 18, 2001
Delayed treatment contributes to mortality in ICU patients with severe active pulmonary tuberculosis and acute respiratory failureJ R Zahar, E Azoulay, E Klement, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2014
Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coliH Guet-Revillet, A Emirian, M Groh, et al.
Intensive Care Medicine|September 3, 2013
Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse eventsJ R Zahar, M Garrouste-Orgeas, A Vesin, et al.
The Journal of Hospital Infection|February 13, 2021
Risk factors for the environmental spread of different multidrug-resistant organisms: a prospective cohort studyR Saliba, T Ghelfenstein-Ferreira, A Lomont, et al.
The Journal of Hospital Infection|August 28, 2025
A proof of concept, evaluation of dry heat as an aerial disinfection method for hospitals: preliminary data for bactericidal efficacyC Djayet, A Iwanoff, M Boubaya, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Antimicrobial Resistance and Infection Control|June 10, 2025
Impact of educational interventions provided to patients with a central venous catheter and their informal caregivers: a systematic reviewL Foucault-Fruchard, N van der Mee, C Reinprecht, et al.
The Journal of Hospital Infection|July 13, 2013
Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization?T Goulenok, A Ferroni, E Bille, et al.
International Journal of Antimicrobial Agents|May 7, 2020
SARS-CoV-2 was already spreading in France in late December 2019A Deslandes, V Berti, Y Tandjaoui-Lambotte, et al.
The Journal of Hospital Infection|February 21, 2012
Is hand-rub consumption correlated with hand hygiene and rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE)-acquired infections?J R Zahar, V Masse, L Watier, et al.
Infectious Diseases Now|August 1, 2022
Prevalence and risk factors for carriage of extended-spectrum β-lactamase-producing enterobacteriaceae in rehabilitation wards in FranceI Grall-Zahar, S Rucly, Typhaine Billard-Pomares, et al.
Intensive Care Medicine|May 18, 2001
Delayed treatment contributes to mortality in ICU patients with severe active pulmonary tuberculosis and acute respiratory failureJ R Zahar, E Azoulay, E Klement, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2014
Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coliH Guet-Revillet, A Emirian, M Groh, et al.
Intensive Care Medicine|September 3, 2013
Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse eventsJ R Zahar, M Garrouste-Orgeas, A Vesin, et al.
The Journal of Hospital Infection|February 13, 2021
Risk factors for the environmental spread of different multidrug-resistant organisms: a prospective cohort studyR Saliba, T Ghelfenstein-Ferreira, A Lomont, et al.
The Journal of Hospital Infection|August 28, 2025
A proof of concept, evaluation of dry heat as an aerial disinfection method for hospitals: preliminary data for bactericidal efficacyC Djayet, A Iwanoff, M Boubaya, et al.
Pageof 8